
    
      The FRAGILE protocol is a national multicenter randomized controlled trial (RCT), conducted
      in 8 Brazilian institutions. The study is already approved by a certified ethics committee.
      Funding is provided by a grant from SÃ£o Paulo Research Foundation (FAPESP), which otherwise
      will not have any role in the conduct of the study nor in the analysis nor in the reporting
      of data. A confidentiality agreement regarding data use and the data safety will be monitored
      by an independent monitoring board. All the authors will provide revisions and comments and
      be testifying for the accuracy and completeness of the report, as well as for the fidelity of
      the report to the study protocol.
    
  